StockSelector.com
  Research, Select, & Monitor Saturday, December 15, 2018 6:19:39 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Iovance Biotherapeutics, Inc.$9.68($.23)(2.32%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Iovance Biotherapeutics, Inc. has an overall rank of 5102 out of 7471 stocks based on 4 positive rankings and 7 negative rankings.

Positive Rankings
PEGValue
Iovance Biotherapeutics has a PEG Value of $131.61. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 1,259.64% in the next year. Among companies with a PEG Value above the current stock price, Iovance Biotherapeutics is ranked 73.
Debt-to-Equity
Iovance Biotherapeutics rank is 114
10 Day Gain
Iovance Biotherapeutics rank is 315
Low Put/Call
Iovance Biotherapeutics has a low Put/Call ratio of 0.49 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Iovance Biotherapeutics is ranked 1391.
Negative Rankings
Down EPS Surprise
Iovance Biotherapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROA
Iovance Biotherapeutics rank is 470
Negative ROE
Iovance Biotherapeutics rank is 521
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Iovance Biotherapeutics is ranked 536.
Price-to-Book
Iovance Biotherapeutics rank is 763
90 Day Loss
Iovance Biotherapeutics rank is 921
High vPut/Call
Iovance Biotherapeutics has a high Put/Call ratio of 0.89 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Iovance Biotherapeutics is ranked 1647.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.